Elevai Labs, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Graydon Bensler, with a market cap of $8.1M.
Based on Q1 2026 filing
Common questions about Elevai Labs, Inc.
Elevai Labs, Inc. (ELAB) has a market capitalization of $8.1M and trades on NASDAQ.
Elevai Labs, Inc. has approximately 18 employees.